Sopharma AD (BUL:SFA)
1.880
+0.010 (0.53%)
At close: May 29, 2026
Sopharma AD Ratios and Metrics
Market cap in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,921 | 1,449 | 958 | 910 | 541 | 556 | |
Market Cap Growth | 97.08% | 51.23% | 5.26% | 68.20% | -2.70% | 38.09% |
Enterprise Value | 2,473 | 2,077 | 1,355 | 1,315 | 841 | 888 |
Last Close Price | 3.66 | 2.79 | 1.85 | 1.78 | 1.09 | 1.09 |
PE Ratio | 11.95 | 10.85 | 12.55 | 9.48 | 7.61 | 6.21 |
Forward PE | - | 11.25 | 11.25 | 11.25 | 11.25 | 11.25 |
PS Ratio | 0.71 | 0.55 | 0.45 | 0.48 | 0.32 | 0.35 |
PB Ratio | 1.86 | 1.48 | 1.14 | 1.21 | 0.76 | 0.84 |
P/TBV Ratio | 2.54 | 2.08 | 1.73 | 1.34 | 0.83 | 0.96 |
P/FCF Ratio | 51.60 | - | 22.36 | 44.09 | 5.96 | - |
P/OCF Ratio | 23.53 | 78.10 | 12.49 | 20.21 | 4.92 | - |
EV/Sales Ratio | 0.91 | 0.79 | 0.63 | 0.70 | 0.50 | 0.55 |
EV/EBITDA Ratio | 9.06 | 10.10 | 10.36 | 10.29 | 7.07 | 9.47 |
EV/EBIT Ratio | 12.75 | 15.40 | 17.17 | 14.10 | 9.79 | 14.45 |
EV/FCF Ratio | 66.42 | - | 31.62 | 63.73 | 9.27 | - |
Debt / Equity Ratio | 0.54 | 0.62 | 0.57 | 0.47 | 0.40 | 0.50 |
Debt / EBITDA Ratio | 2.38 | 2.93 | 3.59 | 2.41 | 2.10 | 2.95 |
Debt / FCF Ratio | 14.92 | - | 11.22 | 17.00 | 3.12 | - |
Net Debt / Equity Ratio | 0.50 | 0.55 | 0.53 | 0.30 | 0.37 | 0.45 |
Net Debt / EBITDA Ratio | 2.23 | 2.63 | 3.41 | 1.74 | 2.21 | 3.12 |
Net Debt / FCF Ratio | 13.78 | -20.47 | 10.39 | 10.75 | 2.90 | -3.04 |
Asset Turnover | - | 1.36 | 1.30 | 1.37 | 1.36 | 1.32 |
Inventory Turnover | - | 4.19 | 4.26 | 4.76 | 4.89 | 4.65 |
Quick Ratio | 0.73 | 0.63 | 0.44 | 0.70 | 0.66 | 0.70 |
Current Ratio | 1.38 | 1.30 | 1.10 | 1.29 | 1.41 | 1.35 |
Return on Equity (ROE) | - | 15.52% | 10.07% | 13.59% | 11.10% | 14.97% |
Return on Assets (ROA) | - | 4.35% | 2.98% | 4.21% | 4.37% | 3.14% |
Return on Invested Capital (ROIC) | 9.37% | 8.64% | 6.09% | 8.57% | 7.98% | 6.02% |
Return on Capital Employed (ROCE) | 12.30% | 10.90% | 7.70% | 10.30% | 10.10% | 7.90% |
Earnings Yield | 8.06% | 9.22% | 7.97% | 10.55% | 13.14% | 16.09% |
FCF Yield | 1.94% | -1.83% | 4.47% | 2.27% | 16.77% | -17.32% |
Dividend Yield | 1.53% | - | 2.80% | 18.57% | 18.32% | - |
Payout Ratio | 28.47% | 10.19% | 220.73% | 74.90% | 0.01% | 0.07% |
Buyback Yield / Dilution | -6.70% | 30.63% | -19.21% | -10.64% | 0.36% | 0.31% |
Total Shareholder Return | -5.17% | 30.63% | -16.41% | 7.93% | 18.68% | 0.31% |